Labomed was bought by Italfarmaco in 2009, but aside from that, what have been the main milestones and achievements of Labomed since its creation in 1968?…
In Conversation
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with…
Being an industry giant with operations in over one hundred counties worldwide, what is the role and significance of Colombia for Novartis global? As a global…
Baxter Chile established itself in the country through the acquisition of a local manufacturer in 1995. What have been the main challenges for the company as…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be…
Michael Sean Reilly: General Manager for Pharmaceuticals Juan Carlos Berbessi: Medical Director Maria del Pilar Rubio: Medical Manager for Vaccines Gustavo Zapata: Finance Director Juan Pablo…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret…
What is the role, significance, and importance of the Colombian market within the larger global strategy of Genzyme international? Colombia is a very important country because…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow…
What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all pharmaceutical companies with…
